Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients

BACKGROUND: The mevalonate pathway synthetizes cholesterol, steroid hormones, and non-steriod isoprenoids necessary for cell survival. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is the rate-limiting enzyme of the mevalonate pathway and the target for statin treatment. HMGCR expression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustbée, Emma, Tryggvadottir, Helga, Markkula, Andrea, Simonsson, Maria, Nodin, Björn, Jirström, Karin, Rose, Carsten, Ingvar, Christian, Borgquist, Signe, Jernström, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479235/
https://www.ncbi.nlm.nih.gov/pubmed/26109908
http://dx.doi.org/10.1186/s12907-015-0008-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479235/
https://www.ncbi.nlm.nih.gov/pubmed/26109908
http://dx.doi.org/10.1186/s12907-015-0008-2

Ejemplares similares